血清尿酸水平与心力衰竭患者左心室喷射率之间的相关性
Manvi Sakhuja1, Manish Pendse2, Smita Patil3
1Senior Resident, Department of Internal Medicine, Sir Ganga Ram Hospital, Delhi, India, Orcid: https://orcid.org/0009-0009-0987-2810, Corresponding Author.
The Journal of the Association of Physicians of India
|December 14, 2025
概括
血清尿酸 (SUA) 水平不能可靠地预测心力衰竭的严重程度. 这项研究在心力衰竭患者中发现SUA和左心室喷射率 (LVEF) 之间没有显著的相关性.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心脏衰竭研究研究
背景情况:
- 心力衰竭 (HF) 是一个日益严重的全球健康问题.
- 血清尿酸 (SUA) 正被研究为HF严重程度的潜在生物标志物.
- 在HF中,SUA与左心室喷射分数 (LVEF) 之间的联系需要进一步澄清.
研究的目的:
- 研究心力衰竭患者血清尿酸 (SUA) 水平与左心室喷射率 (LVEF) 之间的相关性.
- 确定SUA是否可以作为HF缩功能障碍严重程度的生物标志物.
主要方法:
- 一项横截面研究包括60名心力衰竭患者.
- 根据LVEF对患者进行分类:HFpEF,HFmrEF和HFrEF.
- 血清尿酸 (SUA) 水平被测量并与LVEF和HF分类相关联.
主要成果:
- 在LVEF和SUA之间观察到一个弱的,统计学上微不足道的负相关性 (r = -0.070,p = 0.599).
- 高尿路血症在减少喷射分数 (HFrEF) 的患者中更为常见.
- 在SUA水平和缩功能障碍的严重程度之间没有发现显著的关系.
结论:
- 血清尿酸 (SUA) 不是可靠的生物标志物,用于评估心力衰竭患者缩功能障碍的严重程度.
- 目前的研究结果表明,SUA在HF的预后作用仍然不确定.
- 建议进行更大,更多样化的研究,以进一步探索SUA在心力衰竭中的作用.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
443
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
443
01:17Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
01:30Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
01:26Heart Failure III: Clinical Manifestations
440
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
440
01:29Heart Failure II: Pathophysiology
668
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
668
01:30Heart Failure IV: Classification and Diagnostic Evaluation
293
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
293